Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PrevPac in Pseudomyxoma Peritonei
NCT02387203Phase 2Active, not recruiting
- Sponsor
- Mercy Medical Center
- Start
- Jan 2015
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of amoxicillin in pseudomyxoma peritonei (PMP), Appendiceal neoplasm, sponsored by Mercy Medical Center. Started Jan 2015; status: active, not recruiting.
02
Drugs
amoxicillin
03
Conditions
pseudomyxoma peritonei (PMP)Appendiceal neoplasm
Beyond the preview
Go deeper on NCT02387203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02387203.